ResMed Inc (RMD)
231.43
-4.01
(-1.70%)
USD |
NYSE |
Nov 14, 16:00
228.97
-2.46
(-1.06%)
After-Hours: 20:00
ResMed Gross Profit (Annual): 2.655B for June 30, 2024
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 2.655B |
June 30, 2023 | 2.356B |
June 30, 2022 | 2.024B |
June 30, 2021 | 1.839B |
June 30, 2020 | 1.718B |
June 30, 2019 | 1.494B |
June 30, 2018 | 1.335B |
June 30, 2017 | 1.172B |
June 30, 2016 | 1.066B |
June 30, 2015 | 1.011B |
June 30, 2014 | 989.79M |
June 30, 2013 | 940.66M |
June 30, 2012 | 820.74M |
June 30, 2011 | 741.33M |
June 30, 2010 | 655.48M |
June 30, 2009 | 553.80M |
Date | Value |
---|---|
June 30, 2008 | 493.75M |
June 30, 2007 | 384.49M |
June 30, 2006 | 376.90M |
June 30, 2005 | 274.86M |
June 30, 2004 | 216.74M |
June 30, 2003 | 173.09M |
June 30, 2002 | 133.25M |
June 30, 2001 | 104.78M |
June 30, 2000 | 84.87M |
June 30, 1999 | 63.80M |
June 30, 1998 | 47.10M |
June 30, 1997 | 31.50M |
June 30, 1996 | 18.90M |
June 30, 1995 | 12.80M |
June 30, 1994 | 8.00M |
June 30, 1993 | 4.80M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
1.718B
Minimum
2020
2.655B
Maximum
2024
2.118B
Average
2.024B
Median
2022
Gross Profit (Annual) Benchmarks
Boston Scientific Corp | 9.895B |
Globus Medical Inc | 1.020B |
Abbott Laboratories | 22.13B |
Becton Dickinson & Co | 9.153B |
Integra Lifesciences Holdings Corp | 884.74M |